基因更新和治疗抑郁症的方法
Jan Koptielow1, Emilia Szyłak1, Olga Szewczyk-Roszczenko2
1Department of Neurology, Medical University of Bialystok, 15-276 Bialystok, Poland.
International journal of molecular sciences
|April 13, 2024
概括
腹痛会导致无法控制的肌肉和运动. 基因研究,包括像VPS16和TOR1A这样的基因,正在推动对这种神经疾病的理解和管理.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
背景情况:
- 腹痛是一种神经系统疾病,其特征是肌肉非自愿收缩,导致异常的姿势和运动.
- 它会影响所有年龄段的个体,显著影响生活质量.
- 了解基因基础对于诊断和治疗至关重要.
研究的目的:
- 为了回顾近期关于 dystonia 遗传起源的进展.
- 总结目前针对焦点 dystonia 的管理策略.
主要方法:
- 关于近期关于 dystonia 遗传学的研究的文献综述.
- 对与 dystonia 相关的遗传变异的分析.
- 临床诊断挑战和治疗方法的总结.
主要成果:
- 包括VPS16,TOR1A,THAP1,GNAL和ANO3在内的几种基因与 dystonia 有关.
- 遗传学的发现提高了对 dystonia 的病因学的理解.
- 由于症状与其他神经系统疾病重叠,临床诊断可能是复杂的.
结论:
- 遗传研究的进步是理解 dystonia 的关键.
- 改进的遗传洞察力可能会导致更好的诊断工具和向治疗.
- 需要进一步的研究来完善焦点 dystonia 的管理策略.
关键词:
这是一种白性动 (blepharospasm).宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia 宫性 dystonia焦点 dystonia 焦点 dystonia 焦点 dystonia 焦点 dystonia 焦点 dystonia 焦点 dystonia 焦点 dystonia或口 dystonia 的情况.性失声症 性失声症相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
674
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
674
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Skeletal Muscle Relaxants: Therapeutic Uses
482
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
482


